Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
An announcement from Giant Biogene Holding Co. Ltd. ( (HK:2367) ) is now available.
Giant Biogene Holding Co., Ltd announced that its controlling shareholder, Juzi Holding Co., Ltd, plans to increase its shareholding in the company by at least HK$200 million within the next three to six months. This move reflects Juzi Holding’s confidence in the company’s growth potential and commitment to its future prospects, while ensuring a sufficient public float of shares.
The most recent analyst rating on (HK:2367) stock is a Buy with a HK$93.70 price target. To see the full list of analyst forecasts on Giant Biogene Holding Co. Ltd. stock, see the HK:2367 Stock Forecast page.
More about Giant Biogene Holding Co. Ltd.
Giant Biogene Holding Co., Ltd is a company incorporated in the Cayman Islands, operating in the biotechnology industry. It focuses on the development and commercialization of biotechnological products and services.
Average Trading Volume: 8,960,189
Technical Sentiment Signal: Buy
Current Market Cap: HK$62.39B
For a thorough assessment of 2367 stock, go to TipRanks’ Stock Analysis page.